The results are consistent with a previous study conducted in the APP23 mouse model of AD, where BDNF mRNA and Congo Red (which can be used as a marker of plaques; (Cohen and Connors, 1987) were double-labeled in cortex (Burbach et al., 2004). The gene discussed is BDNF; the disease is Alzheimer disease.